Metformin, recognized as an insulin sensitizer, has demonstrated efficacy in enhancing endothelial function, with a notable correlation between endothelial function and insulin resistance following treatment in individuals diagnosed with T2DM (129). Here, INS is linked to type 2 diabetes mellitus.